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Abstract
Colorectal cancer is a major cause of morbidity and mortality in the entire world.
Among cancers that affect both men and women, it accounts for >8% of all cancer
incidence, making it the third most common cancer worldwide (behind lung and
breast cancer). There were an estimated 14.1 million cancer cases around the world in
2012-last data available; 7.4 million were in men and 6.7 million in women. Of that,
nearly 1.4 million new cases were from colorectal cancer. And, it has consistently been
shown that the developed world carries the majority of the burden (Australia, New
Zealand, Canada, the United States and parts of Western Europe), likely due to
similarity in lifestyles and diets.
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1. Introduction
Colorectal cancer is a major cause of morbidity and mortality in the entire world. It has
consistently been shown that the developed world carries the majority of the burden — this
includes Australia, New Zealand, Canada, the United States and parts of Western Europe —
likely due to similarity in lifestyles and diets. [9, 12]
Among cancers that affect both men and women, colorectal cancer accounts for >8% of all
cancer incidence, making it the third most common cancer worldwide, behind lung and breast
cancer (Table 1). [1]
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Cancer New cases diagnosed in2012 (1,000s)
Percent of all
cancers*
Worldwide
1 Lung 1,825 13.0
2 Breast 1,677 11.9
3 Colorectal 1,361 9.7
Men
1 Lung 1,242 16.7
2 Prostate 1,112 15.0
3 Colorectal 746 10.0
Women
1 Breast 1,677 25.2
2 Colorectal 614 9.2
3 Lung 583 8.8
*Excludes basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder. Source: GLOBOCAN
2012 v1.1, “Cancer Incidence and Mortality Worldwide”
Table 1. Cancer Incidence Worldwide
There were an estimated 14.1 million cancer cases around the world in 2012. [1] Of those
cancers, 7.4 million were in men, while 6.7 million were in women. [1] Nearly, 1.4 million of
those new cancer cases were from colorectal cancer. [1]
In the United States, the breakdown between genders is similar. Colorectal cancer is the third
most common cancer in both women and men (after breast and prostate cancer, respectively,
and lung cancer). Among both gender groups, it is the second leading cause of cancer deaths
(behind lung cancer), with peak incidence being in the seventh decade of life. [24] In 2015, it
is estimated that there will be 848,200 new cases of cancer among men and 810,000 among
women in 2015 (Table 2). [2] Of those new cancer cases, 8% will comprise of colon and rectal
cancer, with an estimated 69,090 in men and 63,610 in females. [2]
Men
848,200 Male Female
Women
810,000
Prostate 26% 29% Breast
Lung & bronchus 14% 13% Lung & bronchus
Colon & rectum 8% (69,090) 8% (63,610) Colon & rectum
Urinary bladder 7% 7% Uterine corpus
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Men
848,200 Male Female
Women
810,000
Melanoma of skin 5% 6% Thyroid
Non-Hodgkin
lymphoma 5% 4%
Non-Hodgkin
lymphoma
Kidney & renal
pelvis 5% 4% Melanoma of skin
Oral cavity &
pharynx 4% 4% Pancreas
Leukemia 4% 3% Leukemia
Liver &
intrahepatic bile duct 3% 3%
Kidney & renal
pelvis
All other sites 21% 21% All other sites
*Excludes basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder.
Source: American Cancer Society, ―Cancer Facts and Figures 2015.‖ Projected cases are based on incidence data during
1995-2011 from 49 states and the District of Columbia, as reported by the North American Association of
Central Cancer Registries (NAACCR).
Note: Estimates should not be compared with those from previous years.
Table 2. Estimated New Cancer Cases* in the U.S. in 2015
2. Clinical presentation of colorectal cancer
The importance of screening is crucial as most early-stage colorectal cancer does not typically
have symptoms. In fact, colorectal cancer may be quiescently growing for as long as 5 years
before symptoms appear.
2.1. Signs and symptoms
Symptoms can be specific, such as abdominal discomfort and alarming changes in bowel
movements (i.e., hematochezia, diarrhea, or obstruction). More often than not, however,
symptoms are usually nonspecific, such as fatigue, weight loss, and/or changes in digestion.
As such, even those with some type of symptoms have been misdiagnosed with other benign
conditions. These benign conditions include examples such as diverticular disease, inflam‐
matory bowel syndrome, or hemorrhoids. [4]
The major biochemical sign is that of new onset anemia. In fact, in those older than 40 years
old, a new onset anemia — specifically hypochromic and microcytic — should prompt
evaluation for colorectal cancer.
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2.2. Right-sided colon cancers
Symptoms depend somewhat on the site of the tumor. In general, right-sided colon cancers
are usually detected at an advanced stage with severe symptoms. In general, the right-sided
colon cancers are commonly larger, producing vague abdominal discomfort and sometimes a
palpable mass. [4, 5] Obstruction is rarely a presenting symptom, as the diameter of the right
colon is larger than the left colon. [4] If the tumor involves the cecum, however, it could block
the ileocecal valve causing small bowel obstruction.
Those with right-sided colon cancers are significantly older and are predominantly women
(46% women versus 38% men). [6] Because of higher rates of comorbidities, survival is worse
in those with right-sided carcinomas.
2.3. Left-sided colon cancers and rectal cancers
In comparison, left-sided colon cancers and rectal cancers tend to arise in younger, male
populations with high-incidence risk. [7, 8] Cancers involving this portion of the bowel
produce symptoms that range from obstruction to tenesmus, to alternating constipation and
diarrhea with pencil-thin stools. [4] Often, there is blood witnessed either in the stool or coating
the stool, in comparison to the right-sided colon cancers. Similarly, rectal cancers can cause
obstruction and similar types of bowel movement changes as the left-sided carcinomas.
3. Risk factors of colorectal cancer
There are both modifiable and nonmodifiable risk factors associated with the incidence of
colorectal cancer (Table 3).
Modifiable Risk Factors Nonmodifiable Risk Factors
Diet
Physical activity
Body weight
Social behaviors (i.e., alcohol and cigarette smoking)
Age (≥50 years old)
Personal history of adenomatous colonic polyps
Family history of colorectal cancer
Hereditary polyposis conditions
Personal history of inflammatory bowel disease (IBD)
Table 3. Factors Associated with Higher Risk of Colon and Rectal Cancer
Modifiable risk factors include diet, physical activity, weight, cigarette-smoking, and alcohol
intake. [9] Other modifiable risk factors include low calcium content, low selenium content,
and very low salt intake. [10] Occupational hazards, such as asbestos-exposure, have been
linked to increased risk of colorectal cancer when compared to the rest of the general popula‐
tion. [10]
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Socioeconomic factors, along with access to (and use of) health care services, are also important
contributing risk factors. In fact, there is a disproportionately high incidence of colorectal
cancers in low socioeconomic status populations. [11]
Nonmodifiable risk factors associated with higher risk of colorectal cancer include increasing
age, personal history of adenomatous polyps, personal history of inflammatory bowel disease,
genetic inheritance, race/ethnicity, and gender. [9] Unlike modifiable risk factors that could
theoretically have been avoided, these risk factors are not considered part of the “environ‐
mental nature” of this disease. Thus, they are not controllable. They do, however, play an
important role in screening and identifying susceptible patients.
3.1. Modifiable risk factors: Diet
Diets associated with high incidence of colorectal cancer include diets with high consumption
of red or processed meat, diets high in fat, beer-drinking, diets low in calcium intake, and diets
low in whole-grain fiber, fruits and vegetables. [9] This represents a typical “Western diet.”
On average, 40–45% of Western diets have total caloric intake made up from fatty foods
(including meat products), while fat only accounts for about 10–15% of dietary makeup in
lower-risk populations — China, India, and parts of Africa and South America. Conse‐
quently, it has been shown that the developed world carries the majority of the burden
(Australia, New Zealand, Canada, the United States and parts of Western Europe), [9, 12] likely
due to similarity in lifestyles and diets.
The hypothesis behind dietary fat as a risk factor is that the fat enhances hepatic cholesterol
and bile acid synthesis resulting in increased sterols in the colon. [4] Those sterols are then
converted into secondary bile acids, cholesterol metabolites, and potentially toxic metabolic
compounds. [4, 13]
While the exact pathogenesis remains unknown, what is known is that these sterols and bile
acid metabolites cause damage to colonic mucosa, thus enhancing proliferative activity which
could lead to dysplasia. [4, 13] This has been demonstrated in animal models, where animals
fed polyunsaturated and saturated fats have higher numbers of adenocarcinoma than those
on a low-fat diet. [4] This has also been shown in human population studies where those with
colorectal cancer tend to have higher fecal bile acid levels, [4] while a recent meta-analysis has
shown that consumption of red meat and processed meat is positively associated with risk of
both colon — particularly the descending and sigmoid colon — and rectal cancer. [14]
The “Western diet” also comprises of lower amounts of fiber intake. Multiple epidemiology
studies have shown a geographical difference of lower colorectal cancer incidence rates in
places with higher fiber intake. [9] It is even postulated that due to the ability of fiber to change
the colonic pH, carcinogenesis may be impeded. [4, 9]
Dietary fiber also increases fecal bulk, thus diluting the aforementioned carcinogenic com‐
pounds and reducing transit time and mucosal contact. In fact, fiber has been found to decrease
the concentration of sterol and bile acid metabolites that could be implicated in creating
carcinogenic compounds. [4] Again, this has been demonstrated in animal models, where
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increased fiber intake led to decreased concentration of specific bacterial metabolic enzymes
that could be implicated in creating carcinogenic compounds. [4] Unfortunately, for all its
experimentally demonstrative protective roles, increased fiber supplementation has been
unable to prevent adenoma recurrence in several randomized-controlled trials.
3.2. Modifiable risk factors: Physical activity and body weight
Other modifiable risk factors are physical inactivity and excess body weight. Decreased gut
motility, increased insulin resistance, lower metabolic rates, and increased circulating estro‐
gens are all mechanisms implicated in the higher risk of colorectal cancer associated with this
modifiable risk factor. [9, 10]
3.3. Modifiable risk factors: Social behaviors
Associated with a higher risk is regular consumption of cigarettes and alcohol. [10] Carcino‐
genic metabolites found in both tobacco and alcohol are considered promoters of tumor
growth, based on experimental studies in animals. [15]
Cigarette-smoking has been attributed to 12% of colorectal cancer deaths, while alcohol
consumption has been linked with early onset colorectal cancers, specifically tumors in the
distal colon. [9, 16, 17] There is information showing that there is higher risk in active smokers
for development of rectal cancer.[9, 18]
3.4. Nonmodifiable risk factors: Age
Increasing age carries a higher likelihood of colorectal cancer, specifically after the age of 40. [2]
Cancer incidence rises progressively after the age of 40 in the general population, with 90%
of colorectal cancers occurring in those aged 50 years and older. [2] In fact, a 50-year old
has 5% chance of developing cancer and 2.5% chance of dying from this cancer after the
age of 80 years. [2, 9]
As such, the US Preventative Task Force (USPSTF) has defined “average risk” as those aged
50 years or more with no personal history of colorectal cancer or adenomas, no inflammatory
bowel disease, and with negative family history. [19] Put in other terms, the incidence rate is
more than 50 times higher in those 60–79 years old than in those less than 40 years old.
In contrast, those with “increased risk” include those with a personal history of colorectal
cancer, personal history of colonic adenomas, family history of sporadic colorectal cancer, as
well as family history of sporadic adenoma. [4, 9]
Finally, those with “high risk” include those with hereditary nonpolyposis colorectal cancer
(Lynch syndrome), polyposis syndromes, and inflammatory bowel diseases (IBD). [4] See below
for a discussion on hereditary polyposis conditions and IBD.
3.5. Nonmodifiable risk factors: Personal history of colonic adenomatous polyps
Carrying a personal history of adenomatous polyps has an increased risk of developing
colorectal cancer, in comparison to those with no history of adenomas. In recent literature, it
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was reported that 95% of sporadic colorectal cancers developed from such adenomas, usually
after a protracted period, which has been estimated anywhere from 5 to 10 years. [4, 9]
However, while nearly all colorectal cancer arise from adenomas, only a small minority of
these dysplastic polyps actually progress to cancer (5% or less). [4]
3.6. Nonmodifiable risk factors: Family history of colonic adenomatous polyps or colorectal
cancer
The majority of cases occur in those with family history of either colorectal cancer or adenom‐
atous cancer. In fact, there is a two- to three-fold increased risk of sporadic cancer in those with
first-degree relatives. This means that up to 20% of those with colorectal cancer have family
members affected by this disease. [4, 9] This risk becomes even higher when there are two or
more relatives involved and when those family members are affected by the disease at an age
younger than 60.
3.7. Nonmodifiable risk factors: Hereditary polyposis conditions
Those with recognized inherited polyposis syndromes carry an even higher risk. Recent
literature estimates that about 5–10% of sporadic colorectal cancers are the outcome of
inherited conditions, such as the familial adenomatous polyposis (FAP) and hereditary
nonpolyposis colorectal cancer (HPNCC). [4, 9]
HPNCC (also called Lynch syndrome) is thought to comprise of about 1–6% of all colorectal
cancers. It carries a lifetime risk of cancer as high as 70–80%. [4, 9] FAP and its variants account
for less than 1% of all colorectal cancer cases, but almost all those diagnosed with this disorder
will develop cancer if the colon is not removed by the age of 40. [4]
Other hereditary conditions that are associated with sporadic colorectal cancers include
Gardner’s syndrome (high-risk), Turcot’s syndrome (high-risk), and Peutz-Jeghers syndrome
(low-to-moderate risk). [4] Appropriate screening recommendations are made for this
population subtype, which will not be discussed here.
3.8. Nonmodifiable risk factors: Personal history of Inflammatory Bowel Disease (IBD)
Those with IBD — ulcerative colitis and Crohn’s disease — also carry an increased risk of
developing colorectal cancer. It has been estimated that the relative risk of colorectal cancer in
patients with IBD ranges from 4- to 20-fold. [4, 9] Thus, appropriate screening recommenda‐
tions are made for this population subtype, which will not be discussed here.
4. Statistics
4.1. Methods
The following statistical data were obtained from the Surveillance, Epidemiology and End
Results (SEER) Program of the National Cancer Institute (NCI), specifically from the data
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previously published in the SEER Cancer Statistic Review (CSR) 1975–2012, which was released
in April 23, 2015. The NCI funds for the program through Centers for Disease Control and
Presentation (CDC), National Program of Cancer Registries, and involved states’ contribu‐
tions.
The SEER program was conceptualized in 1973, with a mission to report the “most recent
cancer incidence, mortality, survival, prevalence, and lifetime risks statistics. It originally only
represented about 10% of the US population.
Since then, it has expanded to include the following population-based cancer registries: Alaska
Native Tumor Registry, Arizona Indians, Cherokee Nation, Connecticut, Detroit, Georgia
Center for Cancer Statistics (Atlanta, Greater Georgia, Rural Georgia), Greater Bay Area Cancer
Registry (San Francisco-Oakland, San Jose-Monterey), Greater California, Hawaii, Iowa,
Kentucky, Los Angeles, Louisiana, New Jersey, New Mexico, Seattle-Puget Sound, and Utah.
This translates to approximately 26% of African Americans, 41% of Hispanics, 43% of Amer‐
ican Indians and Alaska Natives, 54% of Asians, and 71% of Hawaiian/Pacific Islanders. It is
published annually, with 2012 being the most recent year for which data are available.
4.2. Temporal trends in the united states
How common is this cancer? It is estimated that there will be 132,700 new colorectal cancer
cases in 2015. [21] This comprises 8% of all new cancer cases (Figure 1). [21] Of those new cancer
cases, there will be an estimated 49,700 deaths. [21] This comprises 8.4% of all cancer deaths
(Table 4).
―
Colon and 
rectum cancer 
represents 
8.0% of all 
new cancer 
cases in the 
U.S.
Figure 1. Colon and rectum cancer in the U.S.
Who gets this cancer? Colorectal cancer is more common in men than in women. In 2014, there
were a total of 135,260 people diagnosed with colorectal cancer: 70,099 men versus 65,161
women. [22] Based on SEER 18, this means that 48.9 per 100,000 persons new cases were male,
while 37.1 per 100,000 persons were female. [20]
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While colorectal cancer is more common in men than in women, the gender bias is smaller
when all races are included. However, the gender bias remains wide when race and ethnicity
are factored in. The greatest divide was found in African American males versus females, with
61.2 per 100,000 new cases in black men versus 46.0 per 100,000 new cases in black women. [20]
Other race/ethnicities also showed a divide, but not as wide. Hispanic male new cases were
30/100,000 while female new cases were 43.3/100,000. American Indian/Alaska Native male
new cases were 35.7/100,000 while female new cases were 46.3/100,000. Asian/Pacific Islander
male new cases were 31.3/100,000 while female new cases were 42.2/100,000. White male new
cases were 36.3/100,000 while female new cases were 47.8/100,000 (Table 5). [20]
At what age is this cancer most frequently diagnosed? Colorectal cancer is most frequently
diagnosed among those aged 65–74 years old. [20] This age group comprises 23.9% of new
cases. [20] The median age is 68 years old (Table 6; Figure 2).
Common Type of Cancer Estimated
New Cases
2015
Estimated
Deaths
2015
Breast cancer
(female)
231,840 40,290
Lung and
bronchus cancer
221,200 158,040
Prostate cancer 220,800 27,540
Colon & rectal
cancer
132,700 49,700
Bladder cancer 74,000 16,000
Melanoma of the
skin
73,870 9,940
Non-Hodgkin
Lymphoma
71,850 19,790
Thyroid cancer 62,450 1,950
Kidney & renal
pelvis cancer
61,560 14,080
Endometrial
cancer
54,870 10,170
Source: SEER 2015
Table 4. Comparison of Common Cancers
Epidemiology of Colorectal Cancer — Incidence, Lifetime Risk Factors Statistics and Temporal Trends
http://dx.doi.org/10.5772/61945
69
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: SEER 2015
Table 6. Percent of Deaths by Age Group
There is different distribution based on age at diagnosis in different gender groups. In women,
colon cancer tends to arise in an older population (mean age being 73 years old; Figure 2; in
comparison, colon cancer tends to arise in a younger population in men (mean age being 69
years old; Figure 2). [9]
In the younger age groups (all races, both sexes), those <20 years old comprised of 0.1% of new
cases; 20–34 years old comprised of 1.3%; 45–54 years old comprised of 14.5%; 55–64 years old
comprised of 21.5%.
 
Females     Males 
 
 
Non-Hispanic                                                           38.1 49.7
 
 
Hispanic                                               30 43.3
 
 
American Indian/Alaska Native                                                       35.7 46.3
 
 
Asian/Pacific Islander                                                 31.3 42.2
 
 
African-American                                                                      46 61.2
 
 
White                                                        36.3 47.8
 
 
All Races                                                         37.1 48.9
 
Source: SEER 18 2008-2012, Age Adjusted
Table 5. Number of New Colon and Rectal Cancer Cases/100,000 Persons by Race/Ethnicity & Sex
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In the older age groups (all races, both sexes), 75–84 years old comprised of 22.6% (75–84 years
old) and those >84 years old comprised of 12.1%. [20]
What are the survival rates? Based on the data from SEER 18 2005–2011, relative survival
statistics show that 64.9% of people survive 5 years or more after being diagnosed with colon
or rectal cancer (all races/sexes, Figure 3). [20, 22]
 
•
•
•
• Percent 
Surviving 5 
Years
• 2005-2011
64.9%
Figure 3. Relative survival rate of colon or rectal cancer.
Does staging influence survival rates? Cancer stage at diagnosis will determine both treat‐
ment options and has a strong influence on the length of survival. Obviously, the earlier the
cancer is caught, the better the chance of survival.
Current statistics show that 39.5% of colon and rectal cancers are diagnosed at the local stage
(confined to primary site), with a 5-year survival for localized colon and rectal cancer being
very high at 90.1% [20] (Table 7).
Thirty-six percent of cancers in the regional stage (those spread to regional lymph nodes) have
a 70.8% 5-year relative survival rate. [20] Twenty percent of cancers in the distant stage (those
that metastasized) carry a 13.1% 5-year relative survival rate. [20] Lastly, those that are
unstaged (5%) have a 34.5% 5-year survival rate [20] (Table 7).
  Median Age at Diagnosis 68
 
  Male Median Age at
 
69       Diagnosis 
  Female Median Age at
 
73       Diagnosis 
Figure 2. Median age at which colorectal cancer is most frequently diagnosed.
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Does the site of cancer change the incidence? Distribution of colon cancers also vary. This
suggests that there are different pathogenic etiologies and carcinogenic mechanisms involved
in different sites of the colon (and rectum).
The most common tumor locations in decreasing order are the descending colon (40–42%),
rectosigmoid and rectum (30–33%), cecum and ascending colon (25–30%), and transverse colon
(10–13%). [22, 23] In other words, 50% of colon cancers are within reach of a flexible sigmoi‐
doscope [24] (Table 8).
Who dies from this cancer? As with all cancers, the death rates increase with age. Among both
gender groups, it is the second leading cause of cancer deaths — behind lung cancer — with
peak incidence being in the seventh decade of life. [2, 20]
In the United States, colorectal cancer is the second leading cause of death. [2] Unfortunately,
each year there are >55,000 deaths (26,804 men; 24,979 women). [20]
The percent of deaths is highest among those aged 75–84 at 26.6%. [20] The median age at death
is 73 years old (Figure 4). [20] This age group comprises 26.6% of all colorectal cancer deaths
[20] (Table 9).
In the younger age groups (all races, both sexes), percent of deaths in those <20 years old
comprised of 0% of new cases; 20–34 years old comprised of 0.7%; 35–44 years old comprised
of 2.5%; 45–54 years old comprised of 9.3%; 55–64 years old comprised of 17.9%.
In the older age groups (all races, both sexes), percent of deaths in those 65–74 years old
comprised of 22.1% and those >84 years old comprised of 21.0%. [20]
Table 7. 5-Year Relative Survival and Percent of Colon and Rectal Cancer Cases by Stage at Diagnosis [20]
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As more males are diagnosed each year than females, there are more male number of deaths
than females. In all races, there were 18.6 number of deaths per 100,000 males versus 13.1
number of deaths per 100,000 females.
The divide between the genders was even greater when race and ethnicity were factored in.
African American males had the highest number of deaths per 100,000: 26.9 (versus
17.8/100,000 females). [25] Males who were identified as non-Hispanic (but not white or black)
had the second highest number of deaths (18.9/100,000), followed by American Indian/Alaska
Table 8. Incidence Rates of Colon and Rectal Cancer by Location [20]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: SEER 18 2008-2012, All Races/Both Sexes
Table 9. Percent of Deaths by Age Group
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native (18.8/100,000) and whites (18.0/100,000). Black females had the higher number of deaths
per 100,000 (17.8), followed by American Indian/Alaska native (15.6), non-Hispanic (13.4), and
whites (12.7) [20] (Table 10).
 
Female     Male 
 
 
Non-Hispanic                                              13.4         18.9 
 
Hispanic                                  9.6             15.6 
 
American Indian/Alaska Native                                                     15.6  18.8 
 
Asian/Pacific Islander                                  9.4      13 
 
African-American                                                            17.8                    26.9 
 
White                                            12.7         18 
 
All Races                                             13.1         18.6 
Source: U.S. 2008-2012, Age-Adjusted
Table 10. Number of Colon and Rectal Cancer Deaths per 100,000 Persons by Race/Ethnicity & Sex
What are the projection rates of colorectal cancer? Rates of new colon and rectal cancer
diagnosis have been falling each year, over the past 10 years. [26] This is true not only for the
United States but also for New Zealand, Australia, and Western Europe.[9] Despite these
numbers, the death rate has not changed significantly, however (Table 11).
Year 1975 1980 1985 1990 1995 1999 2003 2007
5-Year
Relative
Survival
48.6% 51.1% 58.0% 60.8% 59.7% 64.5% 65.3% 66.5%
 
Source: SEER 9 Incidence & U.S. Mortality 1975-2012, all races/both sexes/rates are age-adjusted
Table 11. Incidence & U.S Mortality 1975-2012
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5. Conclusion
Although new diagnosis rates of colorectal cancer have lowered significantly in both women
and men since 1975, more can be done in terms of screening. The drama in these numbers is
that colorectal cancer is a preventative cancer, both in screening and in identification of
modifiable (i.e., theoretically preventable) risk factors. In fact, if everyone aged 50 years or
older had regular screening tests, at least 60% of deaths from this cancer could have been
avoided. [3, 19] And with the knowledge that the 5-year survival is close to 90% when colorectal
cancer is diagnosed at an early stage, the statistics becomes even more dramatic. Bottom‐
line: colorectal cancer is susceptible to screening and aggressive campaigns toward educating
the public dictate the future of its incidence and survival.
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